参考文献/References:
[1] 胡盛寿. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3): 209-220.
[2] 冯健, 何国祥. 核因子相关因子2与心血管疾病[J]. 心血管病学进展, 2010, 31(6): 869-872.
[3] Nioi P, Nguyen T, Sherratt PJ, et al. The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation[J]. Mol Cell Biol, 2005, 25(24): 10895-10906.
[4] Chowdhry S, Zhang Y, Mcmahon M, et al. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity[J]. Oncogene, 2013, 32(32): 3765-3781.
[5] Wang H, Liu K, Geng M, et al. RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2[J]. Cancer Res, 2013, 73(10): 3097-3108.
[6] Yang Y, Tian T, Wang Y, et al. SIRT6 protects vascular endothelial cells from angiotensinⅡ-induced apoptosis and oxidative stress by promoting the activation of Nrf2/ARE signaling[J]. Eur J Pharmacol, 2019, 859: 172516.
[7] Li M, Liu X, He Y, et al. Celastrol attenuates angiotensinⅡmediated human umbilical vein endothelial cells damage through activation of Nrf2/ERK1/2/Nox2 signal pathway[J]. Eur J Pharmacol , 2017, 797: 124-133.
[8] Tao L, Gu X, Xu E, et al. Osthole protects against Ang II-induced endotheliocyte death by targeting NF-κB pathway and Keap-1/Nrf2 pathway[J]. Am J Transl Res, 2019, 11(1): 142-159.
[9] Li S, Sun Y, Han Z, et al. Cytoprotective effects of euxanthone against ox-LDL-induced endothelial cell injury is mediated via Nrf2[J]. Life Sci, 2019, 223: 174-184.
[10] Mao H, Tao T, Wang X, et al. Zedoarondiol attenuates endothelial cells injury induced by oxidized low-density lipoprotein via Nrf2 activation[J]. Cell Physiol Biochem, 2018, 48(4): 1468-1479.
[11] Wei R, Enaka M, Muragaki Y. Activation of KEAP1/NRF2/P62 signaling alleviates high phosphate-induced calcification of vascular smooth muscle cells by suppressing reactive oxygen species production[J]. Sci Rep, 2019, 9(1): 10366.
[12] Yao L, Wang J, Tian BY, et al. Activation of the Nrf2-ARE signaling pathway prevents hyperphosphatemia-induced vascular calcification by inducing autophagy in renal vascular smooth muscle cells[J]. J Cell Biochem, 2017, 118(12): 4708-4715.
[13] Ji R, Sun H, Peng J, et al. Rosmarinic acid exerts an antagonistic effect on vascular calcification by regulating the Nrf2 signalling pathway[J]. Free Radic Res, 2019, 53(2): 187-197.
[14] 李泽龙, 王茂, 鄢东海, et al. Nrf2与心脏衰老的相关研究进展[J]. 西南国防医药, 2019, 29(1): 97-99.
[15] Chen XJ, Ren SM, Dong JZ, et al. Ginkgo biloba extract-761 protects myocardium by regulating Akt/Nrf2 signal pathway[J]. Drug Des Devel Ther, 2019, 13: 647-655.
[16] Sun J, Yu X, Huangpu H, et al. Ginsenoside Rb3 protects cardiomyocytes against hypoxia/reoxygenation injury via activating the antioxidation signaling pathway of PERK/Nrf2/HMOX1[J]. Biomed Pharmacother , 2019, 109: 254-261.
[17] Lian Y, Xia X, Zhao H, et al. The potential of chrysophanol in protecting against high fat-induced cardiac injury through Nrf2-regulated anti-inflammation, anti-oxidant and anti-fibrosis in Nrf2 knockout mice[J]. Biomed Pharmacother , 2017, 93: 1175-1189.
[18] Li S, Wang W, Niu T, et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction[J]. Oxid Med Cell Longev, 2014, 2014: 748524.
[19] Amaral JH, Rizzi ES, Alves-Lopes R, et al. Antioxidant and antihypertensive responses to oral nitrite involves activation of the Nrf2 pathway[J]. Free Radic Biol Med, 2019, 141: 261-268.
[20] Lopes RA, Neves KB, Tostes RC, et al. Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension[J]. Hypertension, 2015, 66(6): 1240-1250.
[21] Ge ZD, Lian Q, Mao X, et al. Current status and challenges of NRF2 as a potential therapeutic target for diabetic cardiomyopathy[J]. Int Heart J, 2019, 60(3): 512-520.
[22] Li L, Luo W, Qian Y, et al. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses[J]. Phytomedicine, 2019, 59: 152774.
[23] Li C, Zhang J, Xue M, et al. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart[J]. Cardiovasc Diabetol, 2019, 18(1): 15.
[24] Gu L, Ye P, Li H, et al. Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE(-/-) mice by up-regulating heme oxygenase-1 via PI3K/Akt/Nrf2/ARE pathway[J]. FASEB J, 2019, 33(4): 4836-4850.
[25] Liu QQ, Ren K, Liu SH, et al. MicroRNA-140-5p aggravates hypertension and oxidative stress of atherosclerosis via targeting Nrf2 and Sirt2[J]. Int J Mol Med, 2019, 43(2): 839-849.